CD38 +CD3+staining | No of cases |
>50% | 12 |
>10% | 23 |
>1% | 14 |
<1% | 1 |
Total no of cases | 50 |
Tumor samples from NKTL patients (n=50) were analyzed for CD38 and CD3 expression by multiplexed immunofluorescence. The percentage of CD38+CD3+ staining was calculated by taking the percentage of CD38+CD3+ positive cells over total CD3+ positive cells in the tumor sample.
EBV, Epstein-Barr virus; NKTL, natural killer T-cell lymphoma; PTCL, peripheral T-cell lymphoma.